ID   MRP1_MOUSE              Reviewed;        1528 AA.
AC   O35379;
DT   27-SEP-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   07-APR-2021, entry version 171.
DE   RecName: Full=Multidrug resistance-associated protein 1 {ECO:0000305};
DE            EC=7.6.2.2 {ECO:0000269|PubMed:9281595};
DE   AltName: Full=ATP-binding cassette sub-family C member 1;
DE   AltName: Full=Glutathione-S-conjugate-translocating ATPase ABCC1 {ECO:0000305};
DE            EC=7.6.2.3 {ECO:0000269|PubMed:9359705};
DE   AltName: Full=Leukotriene C(4) transporter;
DE            Short=LTC4 transporter;
GN   Name=Abcc1 {ECO:0000312|MGI:MGI:102676};
GN   Synonyms=Abcc1a, Abcc1b, Mdrap, Mrp;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Muscle;
RX   PubMed=8649356;
RA   Stride B.D., Valdimarsson G., Gerlach J.H., Wilson G.M., Cole S.P.C.,
RA   Deeley R.G.;
RT   "Structure and expression of the messenger RNA encoding the murine
RT   multidrug resistance protein, an ATP-binding cassette transporter.";
RL   Mol. Pharmacol. 49:962-971(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Testis;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=9281595; DOI=10.1124/mol.52.3.344;
RA   Stride B.D., Grant C.E., Loe D.W., Hipfner D.R., Cole S.P.C., Deeley R.G.;
RT   "Pharmacological characterization of the murine and human orthologs of
RT   multidrug-resistance protein in transfected human embryonic kidney cells.";
RL   Mol. Pharmacol. 52:344-353(1997).
RN   [4]
RP   DISRUPTION PHENOTYPE, FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL
RP   PROPERTIES.
RX   PubMed=9359705; DOI=10.1038/nm1197-1275;
RA   Wijnholds J., Evers R., van Leusden M.R., Mol C.A., Zaman G.J., Mayer U.,
RA   Beijnen J.H., van der Valk M., Krimpenfort P., Borst P.;
RT   "Increased sensitivity to anticancer drugs and decreased inflammatory
RT   response in mice lacking the multidrug resistance-associated protein.";
RL   Nat. Med. 3:1275-1279(1997).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-878 AND SER-882, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19144319; DOI=10.1016/j.immuni.2008.11.006;
RA   Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,
RA   Thibault P.;
RT   "The phagosomal proteome in interferon-gamma-activated macrophages.";
RL   Immunity 30:143-154(2009).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-277; SER-290; SER-878 AND
RP   SER-882, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Lung, Pancreas, Spleen,
RC   and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [7]
RP   SUCCINYLATION [LARGE SCALE ANALYSIS] AT LYS-504, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=23806337; DOI=10.1016/j.molcel.2013.06.001;
RA   Park J., Chen Y., Tishkoff D.X., Peng C., Tan M., Dai L., Xie Z., Zhang Y.,
RA   Zwaans B.M., Skinner M.E., Lombard D.B., Zhao Y.;
RT   "SIRT5-mediated lysine desuccinylation impacts diverse metabolic
RT   pathways.";
RL   Mol. Cell 50:919-930(2013).
CC   -!- FUNCTION: Mediates export of organic anions and drugs from the
CC       cytoplasm. Mediates ATP-dependent transport of glutathione and
CC       glutathione conjugates, leukotriene C4, estradiol-17-beta-o-
CC       glucuronide, methotrexate, antiviral drugs and other xenobiotics.
CC       Confers resistance to anticancer drugs by decreasing accumulation of
CC       drug in cells, and by mediating ATP- and GSH-dependent drug export
CC       (PubMed:9281595, PubMed:9359705). Hydrolyzes ATP with low efficiency.
CC       Catalyzes the export of sphingosine 1-phosphate from mast cells
CC       independently of their degranulation (By similarity). Participates in
CC       inflammatory response by allowing export of leukotriene C4 from
CC       leukotriene C4-synthezing cells (PubMed:9359705).
CC       {ECO:0000250|UniProtKB:P33527, ECO:0000269|PubMed:9281595,
CC       ECO:0000269|PubMed:9359705}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H(2)O + xenobiotic(Side 1) = ADP + phosphate +
CC         xenobiotic(Side 2).; EC=7.6.2.2;
CC         Evidence={ECO:0000269|PubMed:9359705};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an S-substituted glutathione(in) + ATP + H2O = ADP + an S-
CC         substituted glutathione(out) + H(+) + phosphate;
CC         Xref=Rhea:RHEA:19121, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:90779,
CC         ChEBI:CHEBI:456216; EC=7.6.2.3;
CC         Evidence={ECO:0000269|PubMed:9359705};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19122;
CC         Evidence={ECO:0000269|PubMed:9359705};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O + leukotriene C4(in) = ADP + H(+) + leukotriene
CC         C4(out) + phosphate; Xref=Rhea:RHEA:38963, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:57973, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000269|PubMed:9281595, ECO:0000269|PubMed:9359705};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38964;
CC         Evidence={ECO:0000269|PubMed:9281595};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O + sphing-4-enine 1-phosphate(in) = ADP + H(+) +
CC         phosphate + sphing-4-enine 1-phosphate(out); Xref=Rhea:RHEA:38951,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:60119, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:P33527};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38952;
CC         Evidence={ECO:0000250|UniProtKB:P33527};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=17beta-estradiol 17-O-(beta-D-glucuronate)(in) + ATP + H2O =
CC         17beta-estradiol 17-O-(beta-D-glucuronate)(out) + ADP + H(+) +
CC         phosphate; Xref=Rhea:RHEA:60128, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:82961, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:P33527};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:60129;
CC         Evidence={ECO:0000250|UniProtKB:P33527};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O + vincristine(in) = ADP + H(+) + phosphate +
CC         vincristine(out); Xref=Rhea:RHEA:60160, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:143658, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000269|PubMed:9281595};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:60161;
CC         Evidence={ECO:0000269|PubMed:9281595};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + daunorubicin(in) + H2O = ADP + daunorubicin(out) + H(+)
CC         + phosphate; Xref=Rhea:RHEA:33147, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:64677, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:P33527};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33148;
CC         Evidence={ECO:0000250|UniProtKB:P33527};
CC   -!- ACTIVITY REGULATION: MK 571 inhibits sphingosine 1-phosphate and
CC       leukotriene C4 export. {ECO:0000250|UniProtKB:P33527}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=60 nM for leukotriene C4 {ECO:0000269|PubMed:9281595};
CC         KM=3.3 nM for S-(2,4-dinitrophenyl)glutathione
CC         {ECO:0000269|PubMed:9359705};
CC         Vmax=350 pmol/min/mg enzyme for leukotriene C4 transport
CC         {ECO:0000269|PubMed:9281595};
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass membrane
CC       protein {ECO:0000255|PROSITE-ProRule:PRU00441}.
CC   -!- DISRUPTION PHENOTYPE: Homozygous ABCC1 knockout mice are healthy and
CC       fertile up to at least 12 months of age. They are hypersensitive to
CC       anticancer drugs resulting in an increased loss of body weight and
CC       mortality and have a decreased inflammatory response.
CC       {ECO:0000269|PubMed:9359705}.
CC   -!- SIMILARITY: Belongs to the ABC transporter superfamily. ABCC family.
CC       Conjugate transporter (TC 3.A.1.208) subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF022908; AAB80938.1; -; mRNA.
DR   EMBL; AK029876; BAC26654.1; -; mRNA.
DR   CCDS; CCDS37264.1; -.
DR   RefSeq; NP_032602.1; NM_008576.3.
DR   SMR; O35379; -.
DR   BioGRID; 201374; 5.
DR   STRING; 10090.ENSMUSP00000097743; -.
DR   BindingDB; O35379; -.
DR   ChEMBL; CHEMBL2532; -.
DR   SwissLipids; SLP:000000463; -.
DR   GlyGen; O35379; 2 sites.
DR   iPTMnet; O35379; -.
DR   PhosphoSitePlus; O35379; -.
DR   SwissPalm; O35379; -.
DR   EPD; O35379; -.
DR   jPOST; O35379; -.
DR   MaxQB; O35379; -.
DR   PaxDb; O35379; -.
DR   PRIDE; O35379; -.
DR   ProteomicsDB; 291409; -.
DR   Antibodypedia; 4235; 579 antibodies.
DR   Ensembl; ENSMUST00000100167; ENSMUSP00000097743; ENSMUSG00000023088.
DR   GeneID; 17250; -.
DR   KEGG; mmu:17250; -.
DR   UCSC; uc007yhj.2; mouse.
DR   CTD; 4363; -.
DR   MGI; MGI:102676; Abcc1.
DR   eggNOG; KOG0054; Eukaryota.
DR   GeneTree; ENSGT00940000160271; -.
DR   HOGENOM; CLU_000604_27_3_1; -.
DR   InParanoid; O35379; -.
DR   OMA; PDFTQCF; -.
DR   OrthoDB; 138195at2759; -.
DR   PhylomeDB; O35379; -.
DR   TreeFam; TF105199; -.
DR   Reactome; R-MMU-189483; Heme degradation.
DR   Reactome; R-MMU-196741; Cobalamin (Cbl, vitamin B12) transport and metabolism.
DR   Reactome; R-MMU-2142691; Synthesis of Leukotrienes (LT) and Eoxins (EX).
DR   Reactome; R-MMU-382556; ABC-family proteins mediated transport.
DR   BioGRID-ORCS; 17250; 6 hits in 53 CRISPR screens.
DR   ChiTaRS; Abcc1; mouse.
DR   PRO; PR:O35379; -.
DR   Proteomes; UP000000589; Chromosome 16.
DR   RNAct; O35379; protein.
DR   Bgee; ENSMUSG00000023088; Expressed in olfactory epithelium and 300 other tissues.
DR   ExpressionAtlas; O35379; baseline and differential.
DR   Genevisible; O35379; MM.
DR   GO; GO:0016324; C:apical plasma membrane; ISO:MGI.
DR   GO; GO:0009925; C:basal plasma membrane; ISO:MGI.
DR   GO; GO:0016323; C:basolateral plasma membrane; ISO:MGI.
DR   GO; GO:0005737; C:cytoplasm; ISO:MGI.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:MGI.
DR   GO; GO:0016328; C:lateral plasma membrane; ISO:MGI.
DR   GO; GO:0016020; C:membrane; ISO:MGI.
DR   GO; GO:0005886; C:plasma membrane; ISO:MGI.
DR   GO; GO:0015431; F:ABC-type glutathione S-conjugate transporter activity; IMP:UniProtKB.
DR   GO; GO:0140359; F:ABC-type transporter activity; ISS:UniProtKB.
DR   GO; GO:0008559; F:ABC-type xenobiotic transporter activity; ISO:MGI.
DR   GO; GO:0042887; F:amide transmembrane transporter activity; ISO:MGI.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATPase activity; ISO:MGI.
DR   GO; GO:0034040; F:ATPase-coupled lipid transmembrane transporter activity; ISO:MGI.
DR   GO; GO:0042626; F:ATPase-coupled transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0046943; F:carboxylic acid transmembrane transporter activity; ISO:MGI.
DR   GO; GO:0015562; F:efflux transmembrane transporter activity; IMP:ARUK-UCL.
DR   GO; GO:0034634; F:glutathione transmembrane transporter activity; IMP:ARUK-UCL.
DR   GO; GO:0005324; F:long-chain fatty acid transporter activity; ISO:MGI.
DR   GO; GO:0042910; F:xenobiotic transmembrane transporter activity; IMP:ARUK-UCL.
DR   GO; GO:1905039; P:carboxylic acid transmembrane transport; ISO:MGI.
DR   GO; GO:0060326; P:cell chemotaxis; ISO:MGI.
DR   GO; GO:1904646; P:cellular response to amyloid-beta; IMP:ARUK-UCL.
DR   GO; GO:0140115; P:export across plasma membrane; IMP:ARUK-UCL.
DR   GO; GO:0034775; P:glutathione transmembrane transport; ISO:MGI.
DR   GO; GO:0071716; P:leukotriene transport; IMP:UniProtKB.
DR   GO; GO:0015911; P:long-chain fatty acid import across plasma membrane; ISO:MGI.
DR   GO; GO:0060548; P:negative regulation of cell death; ISO:MGI.
DR   GO; GO:1901215; P:negative regulation of neuron death; ISO:MGI.
DR   GO; GO:0033700; P:phospholipid efflux; ISO:MGI.
DR   GO; GO:0045332; P:phospholipid translocation; ISO:MGI.
DR   GO; GO:0030335; P:positive regulation of cell migration; ISO:MGI.
DR   GO; GO:0050729; P:positive regulation of inflammatory response; IMP:UniProtKB.
DR   GO; GO:0042493; P:response to drug; IMP:UniProtKB.
DR   GO; GO:0006979; P:response to oxidative stress; ISO:MGI.
DR   GO; GO:0099039; P:sphingolipid translocation; ISO:MGI.
DR   GO; GO:0070633; P:transepithelial transport; ISO:MGI.
DR   GO; GO:0055085; P:transmembrane transport; ISO:MGI.
DR   GO; GO:1990961; P:xenobiotic detoxification by transmembrane export across the plasma membrane; ISO:MGI.
DR   GO; GO:0042908; P:xenobiotic transport; IMP:ARUK-UCL.
DR   Gene3D; 1.20.1560.10; -; 2.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR011527; ABC1_TM_dom.
DR   InterPro; IPR036640; ABC1_TM_sf.
DR   InterPro; IPR003439; ABC_transporter-like.
DR   InterPro; IPR017871; ABC_transporter_CS.
DR   InterPro; IPR005292; Multidrug-R_assoc.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF00664; ABC_membrane; 2.
DR   Pfam; PF00005; ABC_tran; 2.
DR   SMART; SM00382; AAA; 2.
DR   SUPFAM; SSF52540; SSF52540; 2.
DR   SUPFAM; SSF90123; SSF90123; 2.
DR   TIGRFAMs; TIGR00957; MRP_assoc_pro; 1.
DR   PROSITE; PS50929; ABC_TM1F; 2.
DR   PROSITE; PS00211; ABC_TRANSPORTER_1; 2.
DR   PROSITE; PS50893; ABC_TRANSPORTER_2; 2.
PE   1: Evidence at protein level;
KW   ATP-binding; Cell membrane; Glycoprotein; Hydrolase; Membrane;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome; Repeat;
KW   Translocase; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..1528
FT                   /note="Multidrug resistance-associated protein 1"
FT                   /id="PRO_0000093353"
FT   TOPO_DOM        1..33
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        34..54
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        55..74
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        75..95
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        96..100
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        101..121
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        122..133
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        134..154
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        155..172
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        173..193
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        194..317
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        318..338
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        339..364
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        365..385
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        386..441
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        442..462
FT                   /note="Helical; Name=8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        463..465
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        466..486
FT                   /note="Helical; Name=9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        487..548
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        549..569
FT                   /note="Helical; Name=10"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        570..591
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        592..612
FT                   /note="Helical; Name=11"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        613..963
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        964..984
FT                   /note="Helical; Name=12"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        985..1022
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        1023..1043
FT                   /note="Helical; Name=13"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        1044..1086
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        1087..1107
FT                   /note="Helical; Name=14"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        1108
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        1109..1129
FT                   /note="Helical; Name=15"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        1130..1200
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        1201..1221
FT                   /note="Helical; Name=16"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        1222..1223
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        1224..1244
FT                   /note="Helical; Name=17"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   TOPO_DOM        1245..1528
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   DOMAIN          326..609
FT                   /note="ABC transmembrane type-1 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   DOMAIN          644..868
FT                   /note="ABC transporter 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00434"
FT   DOMAIN          971..1253
FT                   /note="ABC transmembrane type-1 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   DOMAIN          1290..1524
FT                   /note="ABC transporter 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00434"
FT   NP_BIND         678..685
FT                   /note="ATP 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00434"
FT   NP_BIND         1324..1331
FT                   /note="ATP 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00434"
FT   MOD_RES         277
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         290
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         504
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0007744|PubMed:23806337"
FT   MOD_RES         878
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19144319,
FT                   ECO:0007744|PubMed:21183079"
FT   MOD_RES         882
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19144319,
FT                   ECO:0007744|PubMed:21183079"
FT   MOD_RES         912
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P33527"
FT   MOD_RES         927
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P33527"
FT   CARBOHYD        19
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1003
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
SQ   SEQUENCE   1528 AA;  171185 MW;  68FD13667D61DBBB CRC64;
     MALRSFCSAD GSDPLWDWNV TWHTSNPDFT KCFQNTVLTW VPCFYLWSCF PLYFFYLSRH
     DRGYIQMTHL NKTKTALGFF LWIICWADLF YSFWERSQGV LRAPVLLVSP TLLGITMLLA
     TFLIQLERRK GVQSSGIMLT FWLVALLCAL AILRSKIISA LKKDAHVDVF RDSTFYLYFT
     LVLVQLVLSC FSDCSPLFSE TVHDRNPCPE SSASFLSRIT FWWITGMMVH GYRQPLESSD
     LWSLNKEDTS EEVVPVLVNN WKKECDKSRK QPVRIVYAPP KDPSKPKGSS QLDVNEEVEA
     LIVKSPHKDR EPSLFKVLYK TFGPYFLMSF LYKALHDLMM FAGPKILELI INFVNDREAP
     DWQGYFYTAL LFVSACLQTL ALHQYFHICF VSGMRIKTAV VGAVYRKALL ITNAARKSST
     VGEIVNLMSV DAQRFMDLAT YINMIWSAPL QVILALYFLW LSLGPSVLAG VAVMILMVPL
     NAVMAMKTKT YQVAHMKSKD NRIKLMNEIL NGIKVLKLYA WELAFQDKVM SIRQEELKVL
     KKSAYLAAVG TFTWVCTPFL VALSTFAVFV TVDERNILDA KKAFVSLALF NILRFPLNIL
     PMVISSIVQA SVSLKRLRIF LSHEELEPDS IERRSIKSGE GNSITVKNAT FTWARGEPPT
     LNGITFSIPE GALVAVVGQV GCGKSSLLSA LLAEMDKVEG HVTLKGSVAY VPQQAWIQND
     SLRENILFGH PLQENYYKAV MEACALLPDL EILPSGDRTE IGEKGVNLSG GQKQRVSLAR
     AVYSNSDIYL FDDPLSAVDA HVGKHIFEKV VGPMGLLKNK TRILVTHGIS YLPQVDVIIV
     MSGGKISEMG SYQELLDRDG AFAEFLRTYA NAEQDLASED DSVSGSGKES KPVENGMLVT
     DTVGKHLQRH LSNSSSHSGD TSQQHSSIAE LQKAGAKEET WKLMEADKAQ TGQVQLSVYW
     NYMKAIGLFI TFLSIFLFLC NHVSALASNY WLSLWTDDPP VVNGTQANRN FRLSVYGALG
     ILQGAAIFGY SMAVSIGGIF ASRRLHLDLL YNVLRSPMSF FERTPSGNLV NRFSKELDTV
     DSMIPQVIKM FMGSLFSVIG AVIIILLATP IAAVIIPPLG LVYFFVQRFY VASSRQLKRL
     ESVSRSPVYS HFNETLLGVS VIRAFEEQER FIHQSDLKVD ENQKAYYPSI VANRWLAVRL
     ECVGNCIVLF AALFAVISRH SLSAGLVGLS VSYSLQITAY LNWLVRMSSE METNIVAVER
     LKEYSETEKE APWQIQETAP PSTWPHSGRV EFRDYCLRYR EDLDLVLKHI NVTIEGGEKV
     GIVGRTGAGK SSLTLGLFRI NESAEGEIII DGVNIAKIGL HNLRFKITII PQDPVLFSGS
     LRMNLDPFSQ YSDEEVWMAL ELAHLKGFVS ALPDKLNHEC AEGGENLSVG QRQLVCLARA
     LLRKTKILVL DEATAAVDLE TDNLIQSTIR TQFEDCTVLT IAHRLNTIMD YTRVIVLDKG
     EVRECGAPSE LLQQRGIFYS MAKDAGLV
//
